Related Experiment Videos
Long-term healing of bone using recombinant human bone morphogenetic protein 2
C A Kirker-Head1, T N Gerhart, S H Schelling
1School of Veterinary Medicine, Tufts University, North Grafton, MA 01536, USA.
Clinical Orthopaedics and Related Research
|September 1, 1995
Summary
Recombinant human bone morphogenetic protein 2 effectively healed large bone defects in sheep, offering a promising alternative to bone autografts in orthopaedic surgery.
Area of Science:
- Orthopaedic Surgery
- Biomaterials Science
- Regenerative Medicine
Background:
- Bone defects pose significant challenges in orthopaedics.
- Autografts, while effective, have limitations such as donor site morbidity.
- Novel bone graft substitutes are needed to improve healing outcomes.
Purpose of the Study:
- To evaluate the efficacy of recombinant human bone morphogenetic protein 2 (rhBMP-2) in healing critical-sized bone defects.
- To compare rhBMP-2 efficacy against traditional autograft methods.
- To assess the safety and bone regeneration potential of rhBMP-2 in a large animal model.
Main Methods:
- A 2.5-cm middiaphyseal segmental defect was created in ovine femora.
- The defect was stabilized with a plate and implanted with rhBMP-2 and demineralized ovine bone matrix.
- Bone healing was assessed over 12 months using radiographic, clinical, gross pathologic, and histologic evaluations.
Main Results:
- Radiographic evidence of bone formation appeared by 2-4 weeks, with union by 12-16 weeks.
- Complete medullary cavity recanalization and neocortex formation were observed by 52 weeks.
- Bone mineral content reached that of intact femora by 16 weeks, with no adverse soft tissue mineralization or excessive callus formation.
Conclusions:
- rhBMP-2, when combined with a suitable carrier, demonstrated successful bone defect healing in sheep.
- The process mimicked normal bone ossification, modeling, and remodeling.
- rhBMP-2 presents a viable alternative to autograft for various orthopaedic applications.